NEW YORK– (BUSINESS WIRE) – Koneksa, the evidence-based digital biomarkers company, announced today a partnership with Beacon Biosignals, the leading computational neurodiagnostics company, to launch a clinical trial to investigate...
Read More
NEW YORK– (BUSINESS WIRE) — Koneksa, the evidence-based digital biomarkers company, announced today an extended partnership with SSI Strategy, a life sciences consulting firm, that will provide both organizations with...
Read More
NEW YORK–(BUSINESS WIRE)–Koneksa, a healthcare technology company developing evidence-based validated digital biomarkers, today announced the launch of a clinical study comparing the treatment effect between at-home mobile spirometry using digital...
Read More
NEW YORK–(BUSINESS WIRE)–Koneksa, a healthcare technology company developing evidence-based validated digital biomarkers, today announced the launch of its clinical pipeline featuring biomarkers across neuroscience, oncology, respiratory, and other therapeutic areas....
Read More
NEW YORK–(BUSINESS WIRE)–Koneksa, a healthcare technology company pioneering digital biomarkers, today announced The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has awarded a second research grant to evaluate Parkinson’s...
Read More
NEW YORK–(BUSINESS WIRE)–Koneksa, a healthcare technology company pioneering digital biomarkers, announced today that it has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF)...
Read More
PHOENIX–(BUSINESS WIRE)–Aural Analytics, Inc., a leader in clinical-grade speech analytics, announced today a partnership with Koneksa, a leader in digital biomarker development, to further strengthen its platform and research capabilities...
Read More
NEW YORK–(BUSINESS WIRE)–Koneksa, the leader in designing and validating digital biomarkers to accelerate drug development, announced today the completion of a $45M Series C financing round, led by AyurMaya, an...
Read More
NEW YORK – November 3, 2021 – Koneksa, the leader in developing and implementing patient-centric digital biomarkers for drug development, today announced that Sanofi, one of the world’s top biopharmaceutical...
Read More
Koneksa will invest in the continued development of its digital platform for integrating wearables, sensors, and other technologies on a global scale. Financing round was led by Spring Mountain Capital...
Read More
Wearable Devices Accurately Measure Heart Rate and Blood Pressure to Detect Drug Treatment Effects NEW YORK, Jan. 24, 2020 /PRNewswire/ — Koneksa Health, the leader in developing and implementing patient-focused digital...
Read More
NEW YORK, Nov. 6, 2019 /PRNewswire/ — Koneksa Health announced today the opening of its new corporate headquarters in New York. The company, which enables the biopharmaceutical industry to develop new medicines using...
Read More
Study suggests wearables offer advantages over traditional methods NEW YORK, Oct. 1, 2019 /PRNewswire/ — Koneksa Health, a private company that enables the biopharmaceutical industry to develop new medicines using digital biomarkers and…
Wearable Devices Help Predict Hospitalization Risk for Patients Receiving Chemoradiotherapy NEW YORK, Sept. 6, 2019 /PRNewswire/ — Koneksa Health today announced a poster presentation of a study expanding initial findings that real-world...
Read More
Digital health company opens London office headed by Peter Kelly, expert in signal-processing algorithms NEW YORK and LONDON, May 15, 2019 /PRNewswire/ — Koneksa Health, a private company that enables the biopharmaceutical industry to...
Read More
